Elanco Animal Health (ELAN) - Total Liabilities
Based on the latest financial reports, Elanco Animal Health (ELAN) has total liabilities worth $6.72 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Elanco Animal Health - Total Liabilities Trend (2016–2025)
This chart illustrates how Elanco Animal Health's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Elanco Animal Health's working capital to evaluate short-term liquidity relative to the company's equity base.
Elanco Animal Health Competitors by Total Liabilities
The table below lists competitors of Elanco Animal Health ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hero MotoCorp Limited
NSE:HEROMOTOCO
|
India | Rs116.42 Billion |
|
IAMGold Corporation
TO:IMG
|
Canada | CA$1.79 Billion |
|
Mowi ASA
OL:MOWI
|
Norway | Nkr5.86 Billion |
|
Vicor Corporation
NASDAQ:VICR
|
USA | $50.76 Million |
|
Sichuan Chuantou Energy Co Ltd
SHG:600674
|
China | CN¥22.59 Billion |
|
Xpeng Inc
NYSE:XPEV
|
USA | $72.08 Billion |
|
Goldenmax International Technology Ltd
SHE:002636
|
China | CN¥3.22 Billion |
|
Belimo Holding
SW:BEAN
|
Switzerland | CHF211.71 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Elanco Animal Health's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ELAN market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Elanco Animal Health's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Elanco Animal Health (2016–2025)
The table below shows the annual total liabilities of Elanco Animal Health from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $6.81 Billion | +4.50% |
| 2024-12-31 | $6.52 Billion | -19.92% |
| 2023-12-31 | $8.14 Billion | -0.77% |
| 2022-12-31 | $8.20 Billion | -8.56% |
| 2021-12-31 | $8.97 Billion | -2.68% |
| 2020-12-31 | $9.22 Billion | +168.02% |
| 2019-12-31 | $3.44 Billion | -8.52% |
| 2018-12-31 | $3.76 Billion | +227.03% |
| 2017-12-31 | $1.15 Billion | +7.25% |
| 2016-12-31 | $1.07 Billion | -- |
About Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide … Read more